Market revenue in 2023 | USD 48.7 million |
Market revenue in 2030 | USD 81.1 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Lutein and zeaxanthin |
Fastest growing segment | Lutein and Zeaxanthin |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Lutein and Zeaxanthin, Antioxidants, Omega-3 Fatty acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin |
Key market players worldwide | Nestle SA, Pfizer Inc, Solstice Medical, Bausch & Lomb Corp, Kemin Industries, Vitabiotics, Lifecare Neuro Products, ZeaVision, EyeScience, NutraChamps |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eye health supplements market will help companies and investors design strategic landscapes.
Lutein and zeaxanthin was the largest segment with a revenue share of 33.06% in 2023. Horizon Databook has segmented the Australia eye health supplements market based on lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme q10, flavonoids, alpha-lipoic acid, astaxanthin covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia eye health supplements market, including forecasts for subscribers. This country databook contains high-level insights into Australia eye health supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account